As of March 2023 Halozyme Therapeutics has a market cap of $5.13 Billion. This makes Halozyme Therapeutics the world's 2320th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $5.13 B | -33.2% |
2022 | $7.69 B | 35.9% |
2021 | $5.66 B | -1.95% |
2020 | $5.77 B | 138.2% |
2019 | $2.42 B | 14.48% |
2018 | $2.11 B | -26.59% |
2017 | $2.88 B | 125.44% |
2016 | $1.27 B | -42.39% |
2015 | $2.22 B | 83.06% |
2014 | $1.21 B | -29.34% |
2013 | $1.71 B | 127.01% |
2012 | $0.75 B | -23.31% |
2011 | $0.98 B | 23.79% |
2010 | $0.79 B | 48.02% |
2009 | $0.53 B | 18% |
2008 | $0.45 B | -17.66% |
2007 | $0.55 B | 0.1% |
2006 | $0.55 B | 404.64% |
2005 | $0.10 B | 1.3% |
2004 | $0.10 B |
On Mar 19th, 2023 the market cap of Halozyme Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $485.31 B | 9,342.76% | ๐บ๐ธ USA |
![]() Pfizer PFE | $230.85 B | 4,391.85% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $318.04 B | 6,088.17% | ๐บ๐ธ USA |
![]() Sanofi SNY | $119.87 B | 2,232.46% | ๐ซ๐ท France |
![]() Baxter BAX | $19.21 B | 273.78% | ๐บ๐ธ USA |
![]() MannKind Corp MNKD | $1.09 B | -78.64% | ๐บ๐ธ USA |